Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea. Meet the team at BIO Korea. Avance Clinical CEO, Yvonne Lungershausen said the decision to open clinical operations in Seoul followed increasing… Source ..read more

Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Dr Alex Kavros as the new Executive Vice President of Global Scientific & Regulatory Affairs. With an impressive career spanning nearly two decades in drug development, regulatory science and operations, Alex brings a wealth of… Source ..read more

Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267) Avance Clinical CEO, Yvonne Lungershausen said the World Vaccine Congress was an… Source ..read more

New Biotech Report by Frost & Sullivan Adelaide, Australia | San Francisco, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings. (read the full article here)… Source ..read more

February 20, 2024 Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks Revolutionizing Clinical Research: Accelerate Innovation with GenAI by Ryght & Avance Clinical Laguna Beach, California – [February 20, 2024] – Ryght, an innovator in generative artificial intelligence (GenAI) technology for the Life Science industry… Source ..read more

This extensive analysis of the biotech landscape has identified the key challenges and solutions for biotechs seeking the right CRO partner to progress their drug development programs. The report noted that biotechs are increasingly wanting to partner with mid-sized, agile, and responsive CROs with a proven ability to rapidly advance quality clinical programs. It found there is a perception among... Source ..read more

Adelaide, Australia | North Carolina, USA – Avance Clinical, the Australian and North American market-leading CRO for biotechs, has signed a strategic technology MOU with leading Korean decentralized clinical trials (DCTs) and eClinical technology company JNPMEDI Inc. The agreement expands Avance Clinical’s capabilities in the Asia-Pacific biotech clinical trials sector. Anne Sim... Source ..read more

Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies. Explore the promising efficacy of psychedelics like psilocybin, MDMA, 5-methoxy-dimethyltryptamine, and ibogaine in treating conditions such as depression, PTSD, anxiety, and substance use disorder. During this webinar, we will: Our... Source ..read more

Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market leading CRO for biotechs, has again been recognised for its contribution to International Health in the 61st Australian Export Awards 2023. The Australian Export Awards ceremony will be held on 30 November in Canberra at Parliament House. CEO Yvonne Lungershausen said... Source ..read more

Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy Symposium in Korea last week. Adelaide, Australia | North Carolina, USA – Avance Clinical, the Australian and North American market-leading CRO for biotechs, was asked to present their GlobalReady drug development solution to more than 45 Korean... Source ..read more